Sanjay K Sahoo provides a live demonstration on how to use the dashboard To increase transparency at FDA the agency has. Suranjan De Deputy Director for CDER's Regulatory Science Staff RSS describes FAERS data content the Individual Case. In this episode of Code to Care we explore Project BEST an innovative initiative that modernizes how the FDA investigates. Jonathan Cohn and Andrew Egger are going live to cover the breaking news that FDA Commissioner Marty Makary has resigned. As scientific and political pressures collide at the FDA regulatory bottlenecks are intensifying That's delaying treatment for. Trump heads to high-stakes summit in China Inside look at quarantine facility for cruise ship passengers China's battle for. Dr Meredith Chuk from CDER's Office of Hematology and Oncology Products and Suranjan De from CDER's Office of. FDA provides a regulatory foundation related to postmarketing drug safety reporting requirements and highlights the importance.
Registrar Corp's webinar provides industry with important information regarding U. S FDA regulation of medical devices. As the passengers are being evacuated from a cruise ship stricken by a hantavirus outbreak former FDA Commissioner Scott. This week on Face the Nation with Margaret Brennan amid the fragile ceasefire with Iran Energy Secretary Chris Wright and. How does the FDA track drug safety in the age of big data It's. This session provided an overview of FDA -USP interactions and emphasized the importance of public standards in. Recapping a year's worth of progress taking a moment to recognize our amazing staff and discussing what's next for the FDA. FDA will host Rare Disease Day a virtual public meeting on Monday February 23 2026 in global observance of Rare Disease.
This presentation provided an overview of the pre-ANDA scientific meeting process related to topics that provide prospective. Suranjan De from CDER's Office of Surveillance Epidemiology discusses plans progress and technical specifications on. In addition, this presentation provided a comprehensive overview of FDA CDER's NextGen Portal and compared functionality before and. The Food and Drug Administration FDA has planned to modernize electronic submission standards for drug biological and. This presentation described the purpose and scope of pre-ANDA product development and pre-submission meetings under. Watch this panel discussion to gain comprehensive insights into the future of the FDA Accelerated Approval Program AAP and. This annual training course provided participants with the essential knowledge and skills to conduct clinical trials effectively.
